Arax Advisory Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.52M | Buy |
34,547
+32,730
| +1,801% | +$9.02M | 0.44% | 51 |
|
|
2025
Q1 | $482K | Buy |
1,817
+171
| +10% | +$45.4K | 0.03% | 323 |
|
|
2024
Q4 | $382K | Buy |
1,646
+1,623
| +7,057% | +$377K | 0.02% | 350 |
|
|
2024
Q3 | $5.05K | Buy |
23
+6
| +35% | +$1.32K | ﹤0.01% | 1709 |
|
|
2024
Q2 | $3.31K | Hold |
17
| – | – | ﹤0.01% | 1781 |
|
|
2024
Q1 | $3.62K | Hold |
17
| – | – | ﹤0.01% | 962 |
|
|
2023
Q4 | $3.5K | Sell |
17
-3
| -15% | -$617 | ﹤0.01% | 952 |
|
|
2023
Q3 | $3.92K | Sell |
20
-6
| -23% | -$1.18K | ﹤0.01% | 924 |
|
|
2023
Q2 | $4.73K | Buy |
26
+3
| +13% | +$546 | ﹤0.01% | 876 |
|
|
2023
Q1 | $4.49K | Buy |
23
+3
| +15% | +$586 | ﹤0.01% | 874 |
|
|
2022
Q4 | $3.38K | Sell |
20
-2
| -9% | -$338 | ﹤0.01% | 872 |
|
|
2022
Q3 | $4K | Buy |
22
+13
| +144% | +$2.36K | ﹤0.01% | 846 |
|
|
2022
Q2 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 933 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | -$1K | – | 1160 |
|
|
2021
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 980 |
|
|
2018
Q3 | – | Sell |
-37
| Closed | -$6K | – | 638 |
|
|
2018
Q2 | $6K | Buy |
37
+4
| +12% | +$649 | ﹤0.01% | 377 |
|
|
2018
Q1 | $5K | Buy |
33
+15
| +83% | +$2.27K | ﹤0.01% | 370 |
|
|
2017
Q4 | $2K | Hold |
18
| – | – | ﹤0.01% | 414 |
|
|
2017
Q3 | $2K | Sell |
18
-52
| -74% | -$5.78K | ﹤0.01% | 410 |
|
|
2017
Q2 | $9K | Buy |
70
+57
| +438% | +$7.33K | ﹤0.01% | 354 |
|
|
2017
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 482 |
|
|
2016
Q4 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 514 |
|